Rps6ka5 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RPS6KA5 mRNA CTD PMID:22079256 Rps6ka5 Rat 1,2-dimethylhydrazine decreases expression ISO Rps6ka5 (Mus musculus) 6480464 1,2-Dimethylhydrazine results in decreased expression of RPS6KA5 mRNA CTD PMID:22206623 Rps6ka5 Rat 1-chloro-2,4-dinitrobenzene affects binding ISO RPS6KA5 (Homo sapiens) 6480464 Dinitrochlorobenzene binds to RPS6KA5 protein CTD PMID:32991956 Rps6ka5 Rat 17beta-estradiol multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RPS6KA5 mRNA CTD PMID:17404688 Rps6ka5 Rat 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of RPS6KA5 mRNA CTD PMID:36804509 Rps6ka5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of RPS6KA5 mRNA CTD PMID:19933214 Rps6ka5 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RPS6KA5 mRNA CTD PMID:34747641 Rps6ka5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [RPS6KA5 protein binds to CYP1A1 enhancer] CTD PMID:24519526 Rps6ka5 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Rps6ka5 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of RPS6KA5 mRNA CTD PMID:25172293 Rps6ka5 Rat 3,4-methylenedioxymethamphetamine decreases expression ISO Rps6ka5 (Mus musculus) 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RPS6KA5 mRNA CTD PMID:26251327 Rps6ka5 Rat 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RPS6KA5 mRNA CTD PMID:30071829 Rps6ka5 Rat 3,4-methylenedioxymethamphetamine decreases methylation ISO Rps6ka5 (Mus musculus) 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of RPS6KA5 promoter CTD PMID:26251327 Rps6ka5 Rat 4,4'-diaminodiphenylmethane increases expression ISO Rps6ka5 (Mus musculus) 6480464 4,4'-diaminodiphenylmethane results in increased expression of RPS6KA5 mRNA CTD PMID:18648102 Rps6ka5 Rat 4,4'-sulfonyldiphenol decreases methylation ISO Rps6ka5 (Mus musculus) 6480464 bisphenol S results in decreased methylation of RPS6KA5 promoter CTD PMID:33297965 Rps6ka5 Rat 4-hydroxyphenyl retinamide decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Fenretinide results in decreased expression of RPS6KA5 mRNA CTD PMID:28973697 Rps6ka5 Rat all-trans-retinoic acid decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of RPS6KA5 mRNA CTD PMID:33167477 Rps6ka5 Rat aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of RPS6KA5 protein CTD PMID:38428544 Rps6ka5 Rat arsenite(3-) increases activity ISO Rps6ka5 (Mus musculus) 6480464 arsenite results in increased activity of RPS6KA5 protein CTD PMID:11689710 Rps6ka5 Rat avermectin decreases phosphorylation ISO RPS6KA5 (Homo sapiens) 6480464 avermectin results in decreased phosphorylation of RPS6KA5 protein CTD PMID:33381906 Rps6ka5 Rat benzene increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Benzene results in increased expression of RPS6KA5 mRNA CTD PMID:33064461 Rps6ka5 Rat benzo[a]pyrene decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of RPS6KA5 mRNA CTD PMID:22228805 Rps6ka5 Rat benzo[a]pyrene affects methylation ISO RPS6KA5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of RPS6KA5 3' UTR CTD PMID:27901495 Rps6ka5 Rat benzo[a]pyrene multiple interactions EXP 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Benzo(a)pyrene promotes the reaction [TNF protein results in increased expression of more ... CTD PMID:25233930 Rps6ka5 Rat beta-naphthoflavone decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of RPS6KA5 mRNA CTD PMID:32858204 Rps6ka5 Rat bis(2-chloroethyl) sulfide decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Mustard Gas results in decreased expression of RPS6KA5 mRNA CTD PMID:18955075 Rps6ka5 Rat bis(2-chloroethyl) sulfide increases phosphorylation ISO Rps6ka5 (Mus musculus) 6480464 Mustard Gas results in increased phosphorylation of RPS6KA5 protein CTD PMID:18200059 Rps6ka5 Rat bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of RPS6KA5 mRNA CTD PMID:35810816 Rps6ka5 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RPS6KA5 mRNA CTD PMID:25181051|PMID:30816183|PMID:34947998 Rps6ka5 Rat bisphenol A increases expression ISO Rps6ka5 (Mus musculus) 6480464 bisphenol A results in increased expression of RPS6KA5 mRNA CTD PMID:35598803 Rps6ka5 Rat bisphenol A increases methylation ISO RPS6KA5 (Homo sapiens) 6480464 bisphenol A results in increased methylation of RPS6KA5 gene CTD PMID:31601247 Rps6ka5 Rat cadmium dichloride increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of RPS6KA5 mRNA CTD PMID:38382870 Rps6ka5 Rat calcitriol decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Calcitriol results in decreased expression of RPS6KA5 mRNA CTD PMID:16002434 Rps6ka5 Rat cannabidiol increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Cannabidiol results in increased expression of RPS6KA5 mRNA CTD PMID:27918106 Rps6ka5 Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of RPS6KA5 mRNA CTD PMID:23125180 Rps6ka5 Rat cocaine increases expression EXP 6480464 Cocaine results in increased expression of RPS6KA5 mRNA; Cocaine results in increased expression of RPS6KA5 more ... CTD PMID:17898221|PMID:25100957 Rps6ka5 Rat cocaine affects response to substance ISO Rps6ka5 (Mus musculus) 6480464 RPS6KA5 affects the susceptibility to Cocaine CTD PMID:16339038 Rps6ka5 Rat cocaine increases activity ISO Rps6ka5 (Mus musculus) 6480464 Cocaine results in increased activity of RPS6KA5 protein CTD PMID:16339038 Rps6ka5 Rat cocaine multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 Cocaine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein; SL more ... CTD PMID:16339038 Rps6ka5 Rat copper atom multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of RPS6KA5 mRNA CTD PMID:30911355 Rps6ka5 Rat copper(0) multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of RPS6KA5 mRNA CTD PMID:30911355 Rps6ka5 Rat cyclosporin A increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Cyclosporine results in increased expression of RPS6KA5 mRNA CTD PMID:20106945 Rps6ka5 Rat decabromodiphenyl ether increases expression ISO RPS6KA5 (Homo sapiens) 6480464 decabromobiphenyl ether results in increased expression of RPS6KA5 protein CTD PMID:31675489 Rps6ka5 Rat deoxynivalenol increases phosphorylation ISO Rps6ka5 (Mus musculus) 6480464 deoxynivalenol results in increased phosphorylation of RPS6KA5 protein CTD PMID:16424113 Rps6ka5 Rat Dibutyl phosphate affects expression ISO RPS6KA5 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of RPS6KA5 mRNA CTD PMID:37042841 Rps6ka5 Rat diclofenac decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Diclofenac results in decreased expression of RPS6KA5 mRNA CTD PMID:26934552 Rps6ka5 Rat dorsomorphin multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Rps6ka5 Rat doxorubicin decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of RPS6KA5 mRNA CTD PMID:29803840 Rps6ka5 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of RPS6KA5 mRNA CTD PMID:29391264 Rps6ka5 Rat ethyl methanesulfonate increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of RPS6KA5 mRNA CTD PMID:23649840 Rps6ka5 Rat fasudil decreases activity ISO RPS6KA5 (Homo sapiens) 6480464 fasudil results in decreased activity of RPS6KA5 protein CTD PMID:10998351 Rps6ka5 Rat fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of RPS6KA5 mRNA CTD PMID:30307764 Rps6ka5 Rat folic acid decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Folic Acid results in decreased expression of RPS6KA5 mRNA CTD PMID:25629700 Rps6ka5 Rat formaldehyde increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Formaldehyde results in increased expression of RPS6KA5 mRNA CTD PMID:23649840 Rps6ka5 Rat FR900359 affects phosphorylation ISO RPS6KA5 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of RPS6KA5 protein CTD PMID:37730182 Rps6ka5 Rat gallic acid multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 Gallic Acid inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KA5 protein] CTD PMID:21420233 Rps6ka5 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RPS6KA5 mRNA CTD PMID:33387578 Rps6ka5 Rat hexane decreases methylation EXP 6480464 n-hexane results in decreased methylation of RPS6KA5 promoter CTD PMID:23740543 Rps6ka5 Rat hydralazine multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS6KA5 mRNA CTD PMID:17183730 Rps6ka5 Rat hydrogen peroxide increases activity ISO Rps6ka5 (Mus musculus) 6480464 Hydrogen Peroxide results in increased activity of RPS6KA5 protein CTD PMID:11689710 Rps6ka5 Rat ivermectin decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Ivermectin results in decreased expression of RPS6KA5 protein CTD PMID:32959892 Rps6ka5 Rat MeIQx increases expression ISO RPS6KA5 (Homo sapiens) 6480464 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of RPS6KA5 mRNA CTD PMID:20816883 Rps6ka5 Rat metformin multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Metformin co-treated with Pioglitazone] results in decreased expression of RPS6KA5 mRNA CTD PMID:32589349 Rps6ka5 Rat metformin decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Metformin results in decreased expression of RPS6KA5 mRNA CTD PMID:32589349 Rps6ka5 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of RPS6KA5 gene CTD PMID:35440735 Rps6ka5 Rat methyl methanesulfonate increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of RPS6KA5 mRNA CTD PMID:23649840 Rps6ka5 Rat mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of RPS6KA5 mRNA CTD PMID:25972201 Rps6ka5 Rat ML-7 decreases activity ISO RPS6KA5 (Homo sapiens) 6480464 ML 7 results in decreased activity of RPS6KA5 protein CTD PMID:12534346 Rps6ka5 Rat Moniliformin decreases expression ISO Rps6ka5 (Mus musculus) 6480464 moniliformin results in decreased expression of RPS6KA5 mRNA CTD PMID:39984025 Rps6ka5 Rat N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases activity ISO RPS6KA5 (Homo sapiens) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of RPS6KA5 protein CTD PMID:10998351|PMID:18377872 Rps6ka5 Rat N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases activity EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of RPS6KA5 protein CTD PMID:15522277 Rps6ka5 Rat nickel sulfate increases expression ISO RPS6KA5 (Homo sapiens) 6480464 nickel sulfate results in increased expression of RPS6KA5 mRNA CTD PMID:22714537 Rps6ka5 Rat niclosamide increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Niclosamide results in increased expression of RPS6KA5 mRNA CTD PMID:36318118 Rps6ka5 Rat Nor-9-carboxy-delta9-THC multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of RPS6KA5 gene CTD PMID:30521419 Rps6ka5 Rat obeticholic acid decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of RPS6KA5 mRNA CTD PMID:27939613 Rps6ka5 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RPS6KA5 mRNA CTD PMID:25729387 Rps6ka5 Rat oxidopamine multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 [benserazide, levodopa drug combination co-treated with Oxidopamine] results in increased phosphorylation of RPS6KA5 protein; [Oxidopamine more ... CTD PMID:17596448|PMID:19187092 Rps6ka5 Rat ozone multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of RPS6KA5 mRNA CTD PMID:35430440 Rps6ka5 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of RPS6KA5 mRNA CTD PMID:33387578 Rps6ka5 Rat paraquat increases expression ISO Rps6ka5 (Mus musculus) 6480464 Paraquat results in increased expression of RPS6KA5 mRNA CTD PMID:28012437 Rps6ka5 Rat phenylephrine multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity more ... CTD PMID:15522277|PMID:19002563 Rps6ka5 Rat pioglitazone multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Metformin co-treated with Pioglitazone] results in decreased expression of RPS6KA5 mRNA CTD PMID:32589349 Rps6ka5 Rat pirinixic acid multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 Rps6ka5 Rat potassium chromate multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RPS6KA5 mRNA CTD PMID:22079256 Rps6ka5 Rat potassium chromate decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of RPS6KA5 mRNA CTD PMID:22079256 Rps6ka5 Rat progesterone multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RPS6KA5 mRNA CTD PMID:17404688 Rps6ka5 Rat quercetin increases phosphorylation ISO RPS6KA5 (Homo sapiens) 6480464 Quercetin results in increased phosphorylation of RPS6KA5 protein CTD PMID:18377872 Rps6ka5 Rat quercetin multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased phosphorylation of RPS6KA5 protein] CTD PMID:18377872 Rps6ka5 Rat Ro 31-8220 decreases activity EXP 6480464 Ro 31-8220 results in decreased activity of RPS6KA5 protein CTD PMID:15522277 Rps6ka5 Rat SB 203580 multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [U 0126 co-treated with SB 203580] inhibits the reaction [sodium arsenite results in increased activity more ... CTD PMID:12547826 Rps6ka5 Rat SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased more ... CTD PMID:15522277 Rps6ka5 Rat SB 431542 multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Rps6ka5 Rat SCH 23390 multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 SCH 23390 inhibits the reaction [[Oxidopamine co-treated with Levodopa] results in increased expression of RPS6KA5 more ... CTD PMID:19187092 Rps6ka5 Rat silicon dioxide increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of RPS6KA5 mRNA CTD PMID:25895662 Rps6ka5 Rat silicon dioxide decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of RPS6KA5 mRNA CTD PMID:29203145 Rps6ka5 Rat silver atom decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Silver results in decreased expression of RPS6KA5 mRNA CTD PMID:27131904 Rps6ka5 Rat silver(0) decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Silver results in decreased expression of RPS6KA5 mRNA CTD PMID:27131904 Rps6ka5 Rat SL-327 multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 SL 327 inhibits the reaction [[benserazide, levodopa drug combination co-treated with Oxidopamine] results in increased more ... CTD PMID:16339038|PMID:17596448 Rps6ka5 Rat sodium arsenate decreases expression ISO Rps6ka5 (Mus musculus) 6480464 sodium arsenate results in decreased expression of RPS6KA5 mRNA CTD PMID:39847705 Rps6ka5 Rat sodium arsenite multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [U 0126 co-treated with SB 203580] inhibits the reaction [sodium arsenite results in increased activity more ... CTD PMID:12547826 Rps6ka5 Rat sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of RPS6KA5 mRNA CTD PMID:35314868 Rps6ka5 Rat sodium arsenite increases expression ISO RPS6KA5 (Homo sapiens) 6480464 sodium arsenite results in increased expression of RPS6KA5 mRNA CTD PMID:39719251 Rps6ka5 Rat sodium arsenite decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of RPS6KA5 mRNA CTD PMID:28595984|PMID:34032870 Rps6ka5 Rat sodium arsenite increases activity ISO RPS6KA5 (Homo sapiens) 6480464 sodium arsenite results in increased activity of RPS6KA5 protein CTD PMID:12547826 Rps6ka5 Rat succimer multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KA5 mRNA CTD PMID:21641980 Rps6ka5 Rat sunitinib increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Sunitinib results in increased expression of RPS6KA5 mRNA CTD PMID:31533062 Rps6ka5 Rat T-2 toxin decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 T-2 Toxin results in decreased expression of RPS6KA5 mRNA CTD PMID:34581912 Rps6ka5 Rat temozolomide increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Temozolomide results in increased expression of RPS6KA5 mRNA CTD PMID:31758290 Rps6ka5 Rat titanium dioxide decreases methylation ISO Rps6ka5 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of RPS6KA5 gene CTD PMID:35295148 Rps6ka5 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RPS6KA5 mRNA CTD PMID:25729387 Rps6ka5 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of RPS6KA5 mRNA CTD PMID:25729387 Rps6ka5 Rat trichostatin A increases expression ISO RPS6KA5 (Homo sapiens) 6480464 trichostatin A results in increased expression of RPS6KA5 mRNA CTD PMID:24935251|PMID:26272509 Rps6ka5 Rat trichostatin A multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Rps6ka5 Rat triphenyl phosphate affects expression ISO RPS6KA5 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of RPS6KA5 mRNA CTD PMID:37042841 Rps6ka5 Rat urethane increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Urethane results in increased expression of RPS6KA5 mRNA CTD PMID:28818685 Rps6ka5 Rat valproic acid multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS6KA5 mRNA CTD PMID:17183730 Rps6ka5 Rat valproic acid decreases methylation ISO RPS6KA5 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of RPS6KA5 gene CTD PMID:28853863|PMID:29154799|PMID:29201983 Rps6ka5 Rat valproic acid increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of RPS6KA5 mRNA CTD PMID:29154799 Rps6ka5 Rat valproic acid decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of RPS6KA5 mRNA CTD PMID:23179753|PMID:28001369 Rps6ka5 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of RPS6KA5 mRNA CTD PMID:18042343 Rps6ka5 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of RPS6KA5 mRNA CTD PMID:19015723 Rps6ka5 Rat Y-27632 decreases activity ISO RPS6KA5 (Homo sapiens) 6480464 Y 27632 results in decreased activity of RPS6KA5 protein CTD PMID:10998351